Use and treatment modalities for SSRI and SNRI antidepressants in Italy during the period 20032009

Current Medical Research and Opinion

Volumn 28, Issue 9, 2012, Pages 1475-1484

  Aguglia, E ^a   Ravasio, R ^b   Simonetti, M ^c   Pecchioli, S ^c   Mazzoleni, F ^d  

^a UNIVERSITY OF CATANIA   (Italy)

^b Springer Healthcare   (Italy)

^c Italian College of General Practitioners   (Italy)

^d Italian Coll of Gen Practitioners   (Italy)

Author keywords

Antidepressants; SNRI; SSRI; Treatment modalities

Indexed keywords

ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; CHOLINESTERASE INHIBITOR; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; NEUROLEPTIC AGENT; OPIATE; PAROXETINE; SELEGILINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; DEPRESSION; DRUG SUBSTITUTION; DRUG UTILIZATION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; MALE; NEUROSIS; PATIENT COMPLIANCE; PRESCRIPTION; PREVALENCE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; DEPRESSION; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 84866705059     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.713341     Document Type: Article

References (41)

1. Available at: http://www.surgeongeneral.gov/library/mentalhealth/[Last accessed August 2011]
2. Nandi A, Beard JR, Galea S. Epidemiologic heterogeneity of common mood and anxiety disorders over the life course in the general population: a systematic review. BMC Psychiatry 2009;9:31
3. Berardi D, Leggieri G, Berti ceroni G, et al. Depression in primary care. A nationwide epidemiological survey. Family Practice 2002;19:397-400
4. Available at: http://www.epicentro.iss.it/temi/mentale/esemed-pres.asp [Last accessed August 2011]
5. Eric Wua, Paul Greenberga, Elaine Yanga, et al. Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antide-pressants. Curr Med Res Opin 2008;24:2805-13
6. Wu EQ, Greenberg PE, Yang E, et al. Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIs. J Med Econom 2009;12: 124-35
7. Weilburg JB. An overview of SSRI and SNRI therapies for depression. Manag Care 2004;13(6 Suppl):25-33
8. Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: A comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:85-102
9. Isacsson G, Boethius G, Henriksson S, et al. Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database. J Affect Disord 1999;53:15-22
10. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 2003;64:1465-75
11. Bulloch AG, Patten SB. Non-adherence with psychotropic medications in the general population. Soc Psychiatry Psychiatr Epidemiol 2010;45:47-56
12. Bauer M, Bschor T, Pfennig A, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 2007;8:67-104
13. Ereshefsky L, Saragoussi D, Despiegel N, et al. The 6-month persistence on SSRIs and associated economic burden. J Med Econ 2010;13:527-36
14. Ufer M, Meyer SA, Junge O, et al. Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis. Pharmacoepidemiol Drug Saf 2007;16:1153-60
15. Demyttenaere K, Bonnewyn A, Bruffaerts R, et al. Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD). J Affect Disord 2008;110:84-93
16. Trifiro G, Barbui C, Spina E, et al. Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. Pharmacoepidemiol Drug Saf 2007;16:552-9
17. Weissman J, Meyers BS, Ghosh S, et al. Sociodemographic and clinical factors associated with antidepressant type in a national sample of the home health care elderly. Gen Hosp Psychiatry 2011;33:587-93
18. Rich CL, Isacsson G. Suicide and antidepressants in south Alabama: evidence for improved treatment of depression. J Affect Disord 1997;45:135-42
19. Percudani M, Barbui C, Fortino I, et al. Antidepressant drug use in Lombardy, Italy: a population-based study. J Affect Disord 2004;83:169-75
20. Poluzzi E, Motola D, Silvani C, et al. Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement. Eur J Clin Pharmacol 2004;59:825-31
21. Guaiana G, Andretta M, Griez E, et al. Sales of antidepressants, suicides and hospital admissions for depression in Veneto Region, Italy, from 2000 to 2005: an ecological study. Ann Gen Psychiatry 2011;10:24
22. Balestrieri M, Carta MG, Leonetti S, et al. Recognition of depression and appropriateness of antidepressant treatment in Italian primary care. Soc Psychiatry Psychiatr Epidemiol 2004;39:171-6
23. Castelpietra G, Morsanutto A, Pascolo-Fabrici E, et al. Antidepressant use and suicide prevention: a prescription database study in the region Friuli Venezia Giulia, Italy. Acta Psychiatr Scand 2008;118:382-8
24. Cricelli C, Mazzaglia G, Samani F, et al. Prevalence estimates of chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med 2003;25:254-7
25. Mazzaglia G, Sessa E, Samani F, et al. Use of Computerized General Practice Database for epidemiological studies in Italy: a comparative study with the official national statistics. J Epidemiol Commun Health 2004;58(Suppl 1):A133
26. Filippi A, Bignamini AA, Sessa E, et al. Secondary prevention of stroke in Italy: a cross-sectional survey in family practice. Stroke 2003;34:1010-14
27. Filippi A, Sabatini A, Badioli L, et al. Effects of an automated electronic reminder in changing prescribing behaviour among general practitioners in Italy: an intervention trial. Diabetes Care 2003;26:1497-500
28. Mazzaglia G, Mantovani LG, Sturkenboom MCJM, et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hyperten 2005;23:2093-100
29. Lucioni C, Mazzi S. Realtà prescrittiva versus standard di consumo nel campo degli inibitori della pompa protonica in Italia. PharmacoEconomics- Italian Research Articles 2003;5:3-10
30. Ravasio R, Polcaro F, Fonticoli L. Analisi della prescrizione di alcuni farmaci antidepressivi in Italia durante il quinquennio 2001-2005. PharmacoEconomics-Italian Research Articles 2009;11:175-86
31. Hess LM, Raebel MA, Conner DA, et al. Adherence: measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006;40:1280-8
32. Gruppo di lavoro OsMed. L'uso dei farmaci in Italia. Rapporto nazionale anno 2009. Roma: Il Pensiero Scientifico Editore, 2010. Available at: www. agenziafarmaco.it [Last accessed June 2012]
33. Bauer M, Monz BU, Montejo AL, et al. Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry 2008;23:66-73
34. Trifirò G, Tillati S, Spina E, et al. A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. Eur J Clin Pharmacol 2012 [Epub Ahead of print]. DOI 10.1007/s00228-012-1319-1
35. Agenzia Italiana del Farmaco A. Rapporto gennaio-settembre 2010
36. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments metaa-nalysis. Lancet 2009;373:746-58
37. Andersson Sundell K, Gissler M, Petzold M, et al. Antidepressant utilization patterns and mortality in Swedish men and women aged 20-34 years. Eur J Clin Pharmacol 2011;67:169-78
38. Tylee A. Depression in Europe: experience from the DEPRES II survey. Depression Research in European Society. Eur Neuropsychopharmacol 2000;10(Suppl 4):S445-8
39. Judd LL, Paulus MJ, Schettler PJ, et al. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 2000;157:1501-4
40. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR D report. Am J Psychiatry 2006;163:1905-17
41. Esposito D, Wahl P, Daniel G, et al. Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States. Clin Ther 2009;31:644-56